Current role
Biotechnology · Healthcare
Board Member
2023-03-30–present
Robert Hofmeister, Ph.D.
Board Member
Alaunos Therapeutics, Inc. (TCRT)Equibles does not estimate personal net worth.
Get an email with a short summary when Alaunos Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get TCRT alertsAbout Robert Hofmeister, Ph.D.
Robert Hofmeister, Ph.D. is recorded as Board Member at Alaunos Therapeutics, Inc. (TCRT) since March 30, 2023. Alaunos Therapeutics, Inc. reported in an 8-K filed April 18, 2025 that Robert Hofmeister, Ph.D. resigned as member of the board of directors, effective April 15, 2025. Alaunos Therapeutics, Inc. reported in an 8-K filed March 30, 2023 that Robert Hofmeister, Ph.D. was appointed director, effective March 30, 2023. Alaunos Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alaunos Therapeutics, Inc. includes Dale Curtis Hogue, Jr. (CEO and Board Member), Heidi Hagen (CEO and Board Member), Holger Weis (CEO, Chairman and Board Member) and 7 others.
“On April 15, 2025, Dr. Hofmeister resigned as a member of the board of directors (the “Board”) of Alaunos Therapeutics, Inc. (the “Company”) with immediate effect.”
“On March 30, 2023, the Board appointed Robert Hofmeister, Ph.D., as a director of the Company effective immediately.”
Affiliation history
-
Current
2023-03-30–present
-
2023-03-30–2025-04-15
Company network
Leadership on record at Alaunos Therapeutics, Inc.
- Dale Curtis Hogue, Jr. CEO, Board Member
- Heidi Hagen CEO, Board Member
- Holger Weis CEO, Chairman, Board Member
- Kevin Boyle CEO, Board Member
- Timothy Cunningham CFO
- Kevin G. Lafond Chief Accounting Officer
- Douglas W. Pagán Board Member
- Elan Z. Ezickson Board Member
- J. Kevin Buchi Board Member
- Laurence J.N. Cooper Board Member